Literature DB >> 10464575

The personal and social consequences of Alzheimer disease.

D W Coon1, E S Edgerly.   

Abstract

Alzheimer disease (AD) has a drastic effect on the lives of those affected by the disease. Surprisingly little research has studied the personal and social consequences for AD patients. Many appear to go through six stages of change as the disease progresses, but any individual's path through the disease may vary substantially. AD also has a drastic effect on family members who serve as caregivers for people with the disease. These effects are much more studied and better documented. The burdens and, in some cases, benefits of the caregiver role differ from person to person. Race and ethnicity are among the variables that seem to play a role in the caregiver's response. The economic costs of AD are considerable, both for "formal" services, paid for in the money economy, and "informal" services, provided without monetary payment. The direct costs, both formal and informal, are largely, but not entirely, borne by the patient and the patient's family. The overall costs to society clearly amount to scores of billions of dollars.

Entities:  

Mesh:

Year:  1999        PMID: 10464575     DOI: 10.1089/gte.1999.3.29

Source DB:  PubMed          Journal:  Genet Test        ISSN: 1090-6576


  4 in total

Review 1.  Mass spectrometry: A platform for biomarker discovery and validation for Alzheimer's and Parkinson's diseases.

Authors:  Eugene M Cilento; Lorrain Jin; Tessandra Stewart; Min Shi; Lifu Sheng; Jing Zhang
Journal:  J Neurochem       Date:  2019-01-31       Impact factor: 5.372

Review 2.  Rivastigmine. A pharmacoeconomic review of its use in Alzheimer's disease.

Authors:  H M Lamb; K L Goa
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

3.  Case Report: Depression vs. Early-Onset Alzheimer Disease: The Genetic Counselor's Role.

Authors:  J S Goldman
Journal:  J Genet Couns       Date:  2001-10       Impact factor: 2.537

Review 4.  Mild cognitive impairment: conceptual, assessment, ethical, and social issues.

Authors:  Perla Werner; Amos D Korczyn
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.